Abstract:Many industrially crystallized compounds are obtained by nucleation and growth from solution.Either for formation or purification of the product, investigation of intermediates, or prevention of crystallization in amorphous products, crystallization is always a key aspect of manufacturing and development, with a significant impact on the efficiency and profitability of the overall process.Especially in the pharmaceutical industry undetected fluctuations in the crystallization process can alter the crystal structure, affecting the safety and the bioavailability of the product.The ability to fully understand crystallization processes, the parameters that influence the yield and stability of a polymorph, solvate or hydrate form (solvents, concentrations, pH, stirrer geometry and speed, reactor geometry, temperature, temperature ramps, pressure, etc.) are of crucial importance in this industry.Therefore, the ability to reliably monitor these precious crystallization processes on-line has become a strong need in the industry.This process understanding is the most critical part for a QbD (Quality by Design) approach.We present the results of in situ crystallization studies of DL-Alanine performed with a slurry flow cell that was integrated in an X-ray diffraction system.The crystallizations were performed from a saturated solution at different pH values.The different crystallization conditions show distinct differences in crystallization initiation and resulting crystal morphology.

Morphological Study of Czochralski-grown Lanthanide Orthovanadate Single Crystals and Implications on the Mechanism of Spiral Formation